Stem Beheer

Beheer criteriumcontroles 3/4

De CEO Stem is David Buzby, benoemd in Sep2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.47% van de aandelen van het bedrijf, ter waarde € 242.05K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.2 jaar en 3.6 jaar.

Belangrijke informatie

David Buzby

Algemeen directeur

US$250.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.5%
Management gemiddelde ambtstermijn	1.2yrs
Gemiddelde ambtstermijn bestuur	3.6yrs

Recente managementupdates

Recent updates

CEO

David Buzby (64 yo)

less than a year

Tenure

US$250,000

Compensatie

Mr. David S. Buzby is Interim CEO of Stem, Inc. from September 16, 2024 and serves as its Executive Chair of the Board since August 06, 2024. He served as Executive Director at Climate Transition Capital A...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
David Buzby	Interim CEO & Executive Chair of the Board	less than a year	US$250.00k	0.47% € 262.8k
Saul Laureles	Chief Legal Officer & Corporate Secretary	3.5yrs	US$2.62m	0.093% € 52.1k
John Carrington	Advisor	less than a year	US$3.88m	0.31% € 174.9k
Brian Thompson	Founder	no data	geen gegevens	geen gegevens
Spencer Hole	Executive VP & Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Michael Carlson	Chief Operating Officer	2.2yrs	geen gegevens	0.083% € 46.6k
Rahul Shukla	Chief Accounting Officer	2.8yrs	geen gegevens	geen gegevens
Albert Hofeldt	Chief Technology Officer	less than a year	geen gegevens	geen gegevens
Theodore Durbin	Head of Investor Relations	no data	geen gegevens	geen gegevens
Kim Homenock	Chief People Officer	2.7yrs	US$2.35m	0.10% € 55.9k
Matthew Tappin	President of Software Division	1.8yrs	geen gegevens	0.010% € 5.7k
Jake Berlin	Senior Vice President of Energy Services Division	no data	geen gegevens	geen gegevens

1.2yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 5QQ0 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.2 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
David Buzby	Interim CEO & Executive Chair of the Board	3.6yrs	US$250.00k	0.47% € 262.8k
Laura Tyson	Lead Independent Director	3.6yrs	US$210.00k	0.030% € 17.1k
Jane Woodward	Independent Director	3.6yrs	US$210.00k	0.030% € 17.1k
Ira Birns	Independent Director	less than a year	US$90.44k	0.015% € 8.4k
Anil Tammineedi	Independent Director	3.6yrs	US$214.00k	0.030% € 17.1k
Adam Daley	Independent Director	3.6yrs	US$210.00k	0.20% € 110.4k
Gerard Cunningham	Independent Director	less than a year	geen gegevens	0.0075% € 4.2k

3.6yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 5QQ0 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).

Stem Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Stem, Inc. Appoints Albert Hofeldt as Chief Technology Officer

Stem, Inc. Announces Chief Executive Officer Changes

Stem, Inc. Announces Chief Executive Officer Changes

CEO & Director recently sold €336k worth of stock

Stem, Inc. Appoints Gerard Cunningham as Board of Director

CEO & Director recently sold €170k worth of stock

Recent updates

Stem, Inc. Updates Earnings Guidance for the Full Year 2024

Third quarter 2024 earnings released: US$0.91 loss per share (vs US$0.49 loss in 3Q 2023)

Stem, Inc. Appoints Albert Hofeldt as Chief Technology Officer

Stem, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Now 25% overvalued

Stem, Inc. Announces Chief Executive Officer Changes

Stem, Inc. Announces Chief Executive Officer Changes

Stem Receives Continued Listing Standard Notice from NYSE

Stem Receives Continued Listing Standard Notice from NYSE

Stem, Inc. Updates Revenue Guidance for the Third Quarter and Fourth Quarter of 2024

New minor risk - Market cap size

Stem, Inc. Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2024

Stem, Inc. to Report Q2, 2024 Results on Aug 06, 2024

CEO & Director recently sold €336k worth of stock

Now 24% undervalued after recent price drop

First quarter 2024 earnings released: US$0.46 loss per share (vs US$0.29 loss in 1Q 2023)

Stem, Inc. Re-affirms Revenue Guidance for the Second, Third and Fourth Quarter of 2024

New minor risk - Shareholder dilution

Stem, Inc. Appoints Gerard Cunningham as Board of Director

Stem, Inc. to Report Q1, 2024 Results on May 02, 2024

CEO & Director recently sold €170k worth of stock

New minor risk - Shareholder dilution

Full year 2023 earnings released: US$0.90 loss per share (vs US$0.81 loss in FY 2022)

Stem, Inc. Provides Earnings Guidance for the Full-Year 2024

New major risk - Financial position

Stem, Inc. to Report Q4, 2023 Results on Feb 28, 2024

New minor risk - Profitability

Stem, Inc. Revises Earnings Guidance for the Full-Year 2023

Stem, Inc. Revises Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings released: US$0.49 loss per share (vs US$0.22 loss in 3Q 2022)

Stem, Inc. Appoints Ira M. Birns to its Board of Directors and as Chair of Audit Committee, Effective November 6, 2023

Stem, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Independent Chairman of the Board recently bought €280k worth of stock

Stem Introduces Athena® PowerBidder™ Pro for Bid Optimization in Wholesale Energy Markets

New minor risk - Profitability

No longer forecast to breakeven

Stem, Inc. Reaffirms Revenue Guidance for the Third Quarter, Fourth Quarter and Full Year 2023

New minor risk - Financial position

Second quarter 2023 earnings released: EPS: US$0.12 (vs US$0.21 loss in 2Q 2022)

Forecast to breakeven in 2025

Stem, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Stem, Inc. Announces Resignation of Lisa L. Troe as Director

Bernstein Liebhard LLP Announces Securities Class Action Lawsuit Has Been Filed Against Stem, Inc

Pomerantz Law Firm Announces the Filing of A Class Action Against Stem, Inc

Stem, Inc. Provides Earnings Guidance for the Second, Third and Fourth Quarter and Full Year of 2023

First quarter 2023 earnings released: US$0.29 loss per share (vs US$0.15 loss in 1Q 2022)

Insider recently sold €74k worth of stock

Stem, Inc. Provides Earnings Guidance for the Full Year 2023

Now 22% undervalued after recent price drop

Stem, Inc. to Report Q4, 2022 Results on Feb 16, 2023

Forecast to breakeven in 2025

Chief Financial Officer recently sold €424k worth of stock

High number of new and inexperienced directors

Third quarter 2022 earnings released: US$0.22 loss per share (vs US$0.85 profit in 3Q 2021)

Stem, Inc. Reaffirms Earnings Guidance for the Fourth Quarter and Fiscal Year 2022

Investor sentiment deteriorated over the past week

Stem, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Investor sentiment deteriorated over the past week

Stem Appoints Michael Carlson as Chief Operating Officer

Stem Announces Unified Athena Platform

Independent Chairman of the Board recently sold €807k worth of stock

Chief Revenue Officer recently sold €670k worth of stock

Stem, Inc. Reaffirms Revenue Guidance for the Third Quarter, Fourth Quarter and Full Year 2022

Second quarter 2022 earnings released: US$0.21 loss per share (vs US$1.00 loss in 2Q 2021)

Stem, Inc. to Report Q2, 2022 Results on Aug 04, 2022

No longer forecast to breakeven

First quarter 2022 earnings released: US$0.15 loss per share (vs US$6.73 loss in 1Q 2021)

Stem, Inc. Reaffirms Earnings Guidance for the Fiscal Year of 2022

Stem, Inc., Annual General Meeting, Jun 15, 2022